» Articles » PMID: 28147337

Clinical Significance of Circulating Tumor Cells in Gastric Cancer Patients

Overview
Journal Oncotarget
Specialty Oncology
Date 2017 Feb 2
PMID 28147337
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Circulating tumor cells (CTCs) are rare cancer cells released from tumors into the blood stream that are thought to have a key role in cancer metastasis. Investigation of CTCs is an exciting area of research but remains in its infancy, and the presence of CTCs has been associated with worse prognosis in several major cancer types. Gastric cancer (GC) is a highly lethal malignancy and a serious public health concern in East Asia especially in China. There is an urgent need for identifying new, better prognostic markers to enhance diagnosis and prognosis, facilitate drug development, and to improve the treatment of gastric cancer patients. There are considerable interests in gastric CTCs given their potential use as gastric cancer biomarkers. This review highlights recent advances in studies of gastric CTCs, including the isolation and biological molecular characteristics of gastric CTCs, and their clinical significance.

Citing Articles

Immunolipid magnetic bead-based circulating tumor cell sorting: a novel approach for pathological staging of colorectal cancer.

Deng Q, Li W, Huang Y, Wang H, Zhou X, Guan Z Front Oncol. 2025; 14:1531972.

PMID: 39927117 PMC: 11803635. DOI: 10.3389/fonc.2024.1531972.


Glycolysis-related genes predict prognosis and indicate immune microenvironment features in gastric cancer.

Xu L, Liu J, An Y, Zhou L, Sun H, Xu Z BMC Cancer. 2024; 24(1):979.

PMID: 39118022 PMC: 11313097. DOI: 10.1186/s12885-024-12747-z.


Circulating tumor cells are a good predictor of tumor recurrence in clinical patients with gastric cancer.

Li W, Zhang X, Yang Y, Lin J, Zhou K, Sun R Sci Rep. 2024; 14(1):12758.

PMID: 38830909 PMC: 11148116. DOI: 10.1038/s41598-024-63305-3.


Liquid biopsy for gastric cancer: Techniques, applications, and future directions.

Diaz Del Arco C, Fernandez Acenero M, Ortega Medina L World J Gastroenterol. 2024; 30(12):1680-1705.

PMID: 38617733 PMC: 11008373. DOI: 10.3748/wjg.v30.i12.1680.


Exosomal circRNAs as promising liquid biopsy biomarkers for glioma.

Wu X, Shi M, Lian Y, Zhang H Front Immunol. 2023; 14:1039084.

PMID: 37122733 PMC: 10140329. DOI: 10.3389/fimmu.2023.1039084.


References
1.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

2.
Yuan D, Chen L, Li M, Xia H, Zhang Y, Chen T . Isolation and characterization of circulating tumor cells from human gastric cancer patients. J Cancer Res Clin Oncol. 2014; 141(4):647-60. DOI: 10.1007/s00432-014-1814-0. View

3.
Camidge D, Bang Y, Kwak E, Iafrate A, Varella-Garcia M, Fox S . Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study. Lancet Oncol. 2012; 13(10):1011-9. PMC: 3936578. DOI: 10.1016/S1470-2045(12)70344-3. View

4.
Gascoyne P, Noshari J, Anderson T, Becker F . Isolation of rare cells from cell mixtures by dielectrophoresis. Electrophoresis. 2009; 30(8):1388-98. PMC: 3754902. DOI: 10.1002/elps.200800373. View

5.
de Bono J, Scher H, Montgomery R, Parker C, Miller M, Tissing H . Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res. 2008; 14(19):6302-9. DOI: 10.1158/1078-0432.CCR-08-0872. View